About the Authors

Jennifer Vomaske

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Ryan M. Melnychuk

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Patricia P. Smith

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Joshua Powell

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Laurel Hall

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Victor DeFilippis

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Klaus Früh

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Martine Smit

Affiliation Leiden/Amsterdam Center for Drug Research, Division of Medicinal Chemistry, Faculty of Chemistry, Amsterdam, The Netherlands

David D. Schlaepfer

Affiliation Department of Immunology, The Scripps Research Institute, La Jolla, California, United States of America

Jay A. Nelson

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Daniel N. Streblow

streblow@ohsu.edu

Affiliation Department of Molecular Microbiology and Immunology and The Vaccine and Gene Therapy Institute, Oregon Health & Science University, Portland, Oregon, United States of America

Competing Interests

OHSU and investigators D. Streblow and J. Nelson have a financial interest in Virogenomics, Inc., a company that has rights to US28. The potential conflict of interest has been reviewed and managed by the OHSU Conflict of Interest in Research Committee.

Author Contributions

Conceived and designed the experiments: JEV KF JAN DNS. Performed the experiments: JEV RMM JDP VD. Analyzed the data: JEV VD. Contributed reagents/materials/analysis tools: PPS JDP LH VD KF MS DDS. Wrote the paper: JEV JAN DNS.